IE51827B1 - Quick disintegrating pressed shapes containing pharmaceutical active substances - Google Patents

Quick disintegrating pressed shapes containing pharmaceutical active substances

Info

Publication number
IE51827B1
IE51827B1 IE2643/81A IE264381A IE51827B1 IE 51827 B1 IE51827 B1 IE 51827B1 IE 2643/81 A IE2643/81 A IE 2643/81A IE 264381 A IE264381 A IE 264381A IE 51827 B1 IE51827 B1 IE 51827B1
Authority
IE
Ireland
Prior art keywords
pharmaceutical active
pressed shapes
active substances
containing pharmaceutical
substances according
Prior art date
Application number
IE2643/81A
Other languages
English (en)
Other versions
IE812643L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE812643L publication Critical patent/IE812643L/xx
Publication of IE51827B1 publication Critical patent/IE51827B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Control Of Presses (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Fertilizing (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Golf Clubs (AREA)
  • Measurement Of Force In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE2643/81A 1980-11-12 1981-11-11 Quick disintegrating pressed shapes containing pharmaceutical active substances IE51827B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH839380 1980-11-12

Publications (2)

Publication Number Publication Date
IE812643L IE812643L (en) 1982-05-12
IE51827B1 true IE51827B1 (en) 1987-04-01

Family

ID=4339640

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2643/81A IE51827B1 (en) 1980-11-12 1981-11-11 Quick disintegrating pressed shapes containing pharmaceutical active substances

Country Status (20)

Country Link
EP (1) EP0052076B1 (enExample)
JP (1) JPS57109715A (enExample)
AT (1) ATE13486T1 (enExample)
AU (1) AU552861B2 (enExample)
CA (1) CA1178202A (enExample)
CY (1) CY1429A (enExample)
DE (1) DE3170764D1 (enExample)
DK (1) DK154537C (enExample)
ES (1) ES506981A0 (enExample)
FI (1) FI76254C (enExample)
GB (1) GB2086725B (enExample)
GR (1) GR76337B (enExample)
HK (1) HK53388A (enExample)
IE (1) IE51827B1 (enExample)
IL (1) IL64255A0 (enExample)
MY (1) MY8700132A (enExample)
NO (1) NO157964C (enExample)
NZ (1) NZ198937A (enExample)
PT (1) PT73963B (enExample)
ZA (1) ZA817795B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
JPH0830005B2 (ja) * 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
CH675537A5 (enExample) * 1988-03-25 1990-10-15 Ciba Geigy Ag
EP0352800A3 (en) * 1988-07-28 1991-05-08 Warner-Lambert Company Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
KR20080083071A (ko) 2003-08-08 2008-09-12 아지노모토 가부시키가이샤 나테글리니드 함유 제제
JP5122380B2 (ja) * 2008-06-16 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の放出を制御した速崩錠及びその製法
EP2253306A1 (en) * 2009-05-18 2010-11-24 Royal College of Surgeons in Ireland Orodispersible dosage forms containing solid drug dispersions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
GB1560475A (en) * 1975-10-11 1980-02-06 Lilly Industries Ltd Pharmaceutical formulation
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet

Also Published As

Publication number Publication date
CA1178202A (en) 1984-11-20
CY1429A (en) 1988-09-02
DK154537C (da) 1989-04-17
DK499181A (da) 1982-05-13
IL64255A0 (en) 1982-02-28
FI76254B (fi) 1988-06-30
ES8303090A1 (es) 1983-02-01
DE3170764D1 (en) 1985-07-04
ATE13486T1 (de) 1985-06-15
ZA817795B (en) 1982-10-27
GR76337B (enExample) 1984-08-04
AU7738281A (en) 1982-05-20
NO813826L (no) 1982-05-13
FI76254C (fi) 1988-10-10
GB2086725B (en) 1985-08-21
GB2086725A (en) 1982-05-19
ES506981A0 (es) 1983-02-01
NO157964C (no) 1988-06-29
MY8700132A (en) 1987-12-31
EP0052076A1 (de) 1982-05-19
IE812643L (en) 1982-05-12
NO157964B (no) 1988-03-14
PT73963A (de) 1981-12-01
DK154537B (da) 1988-11-28
FI813532L (fi) 1982-05-13
HK53388A (en) 1988-07-22
JPS57109715A (en) 1982-07-08
JPH0228564B2 (enExample) 1990-06-25
PT73963B (de) 1983-11-23
NZ198937A (en) 1985-04-30
EP0052076B1 (de) 1985-05-29
AU552861B2 (en) 1986-06-26

Similar Documents

Publication Publication Date Title
US4666703A (en) Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances
CA1178202A (en) Quick-disintegrating pressed shapes containing pharmaceutical active substances
GB2087235A (en) A granular delayed-release form of pharmaceutical active substances
US4728513A (en) Granular delayed-release form of pharmaceutically active substances
US4900557A (en) Pellet formulation
KR970007902B1 (ko) 신규 테트라시클린 화합물의 조절된 방출 제재
US5919485A (en) Oral 2-methyl-thieno-benzodiazepine formulation
KR880002673B1 (ko) 진통 캡슐제와 그 제조방법
US2887438A (en) Prolonged action tablets
NZ227631A (en) Oral composition comprising a mixture of granulates having immediate release properties and sustained release properties
HUP0500832A2 (en) Pharmaceutical pellets comprising tamsulosin and process for making the same
JPH02138210A (ja) 圧縮成型製剤
GB2155330A (en) Solvent granulation technique for forming solid formulation of nystatin
JPS62181214A (ja) 徐放性粒状物の製造法
HU191102B (en) Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons

Legal Events

Date Code Title Description
MM4A Patent lapsed